May 18, 2020 / 8:45 PM / 7 days ago

BRIEF-Arbutus Announces Single-Dose Week 12 Data In Chronic Hepatitis B Subjects

May 18 (Reuters) - Arbutus Biopharma Corp:

* ARBUTUS ANNOUNCES SINGLE-DOSE WEEK 12 DATA IN CHRONIC HEPATITIS B SUBJECTS WITH 60 MG AB-729 DEMONSTRATING A SIGNIFICANT AND CONTINUOUS REDUCTION IN HBSAG

* ARBUTUS BIOPHARMA CORP - MEAN 60 MG HBSAG REDUCTION OF 0.99 LOG10 IU/ML AT WEEK 12, WITH NORMAL ALT AND AST VALUES THROUGHOUT FOLLOW-UP PERIOD Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below